About the event: Eating disorders are serious, life-threatening illnesses, and they often hide in plain sight. Because of misconceptions about how eating disorders present, they too frequently go undiagnosed. In this presentation, Equip researchers will review the available tools for screening for eating disorders—for patients of all ages, in addition to highlighting new research focused on ages 6-12—and discuss the pros and cons of using each in a clinical setting.
Learning objectives: After participating in this session, attendees should be able to:
1. Name currently available eating disorder screening tools
2. Identify gaps in eating disorder screening research
3. Describe how eating disorder screening tools can be used in clinical practice
Accreditation information:
- Eligible providers who attend the webinar will be eligible for up to 1 credit through ACCME or APA.
- Equip designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dr. Baker is Senior Research Manager at Equip Health. Prior to her role at Equip, she served as faculty at the University of North Carolina Center of Excellence for Eating Disorders for almost a decade. Dr. Baker has a PhD in Clinical Psychology with expertise in eating disorders research and treatment.
Dr. Whelen received her PhD in Experimental Psychology from Ohio State University in 2022, where she studied cognitive behavioral therapy. Her interest in real-world applications of clinical psychology research drew her to Equip, where she currently works as a postdoctoral researcher.
Registration cost:Free
We currently offer Continuing Education credits to:
- Physicians (ACCME)
- Licensed psychologists (APA)
- Dietitians and other medical or mental health providers can request to obtain credit through, and at the discretion of, their licensing or credentialing organization
Available CE credits:
- 1 AMA PRA Category 1 Credit™
- 1 APA CE Credit
- 1 CDR CPEU Lecture Hour
Additional CE information
Refund policy: This activity is offered free of charge.
Target audience: The target audience for this presentation includes medical doctors, nurse practitioners, registered dietitians, therapists, case managers, and other health care providers.
Learning format / activity type: Live activity
Continuing Education accreditation:
APA: Equip is approved by the American Psychological Association to sponsor Continuing Education for psychologists. Equip maintains responsibility for this program and its content.
ACCME: Equip is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Other healthcare professionals: We are happy to provide a certificate of attendance for all providers who stayed for the duration of the activity, however, it is up to the individual attendee to determine whether this activity meets the Continuing Education requirements of their licensing or credentialing organization. Please check your state’s rules and regulations for more information regarding your Continuing Education requirements.
Attendance: Full attendance is required to earn Continuing Education credit through the APA. It is up to each individual attendee to determine whether this activity meets the Continuing Education requirements of their licensing or credentialing organization. Please check your state’s rules and regulations for more information regarding your Continuing Education requirements.
Disclosures:
- Equip receives no commercial funding for these activities.
- The presenter(s) mentioned above, faculty for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose. Natalia Orloff, PhD, Jessie Menzel, PhD, Cara Bohon, PhD, and Angela Celio Doyle, PhD, FAED, planners for this educational activity, have no relevant financial relationships with ineligible companies to disclose.
- Maria La Via, MD, planner for this educational activity, owns individual stock in the following ineligible companies: Danahar, Gilead, 3M, GSK, Merck, Seres Therapeutics, Solventum, Novavax, Organon, Pfizer, and Viatris. All of the relevant financial relationships listed for these individuals have been mitigated.
Questions?
Contact ce@equip.health